MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
URGN UroGen Pharma Ltd
- 10.640
- -0.070-0.65%
Close Dec 20 16:00 ET
- 10.640
- 0.0000.00%
Post 16:20 ET
449.00MMarket Cap-3.52P/E (TTM)
11.080High10.510Low1.40MVolume10.650Open10.710Pre Close14.88MTurnover4.32%Turnover RatioLossP/E (Static)42.20MShares20.70052wk High17.59P/B344.19MFloat Cap10.51052wk Low--Dividend TTM32.35MShs Float69.568Historical High--Div YieldTTM5.32%Amplitude4.850Historical Low10.653Avg Price1Lot Size
UroGen Pharma Ltd Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 30, 2024
The average UroGen Pharma Ltd stock price target is 41.00 with a max estimate of 64.00 and a min estimate of 25.00
Review UroGen Pharma Ltd earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Nov 30, 2024